BENJAMIN LEISHMAN, OD
Vision Therapy Optometrist in SANDY, Utah. CMS National Plan and Provider Enumeration System profile including specialty classification, practice address, and Medicare prescribing data when reported.
What stands out: BENJAMIN LEISHMAN, OD filed 39 Medicare Part D claims in 2023 across SANDY, Utah. Every figure on this page comes straight from federal CMS records, with no proprietary rating applied.
BENJAMIN LEISHMAN, OD at a glance
Quality data not reportedPrimary specialty
Medicare Part D claims
Specialty distribution in Utah
How Vision Therapy Optometrist compares to other specialties among Utah providers
Vision Therapy Optometrist share within Utah
Vision Therapy Optometrist is one of the more visible NUCC categories in Utah
Each bar reflects the share of in-state providers whose primary NUCC taxonomy matches the specialty. Long tail of ~690 NUCC codes folded into "Other" to keep the comparison legible.
Specialty board-certification context
Estimated specialty board-certified rate — Vision Therapy Optometrist (ABMS / AOA reference)
- Est. board-certified rate
- 78%
- Vision Therapy Optometrist ABMS/AOA estimate
Est. board-certified rate (Vision Therapy Optometrist) — ABMS / AOA estimate
Verify credentials
- Verify via ABMS free public lookup
- Verify via AOA osteopathic boards
- Specialty volume Vision Therapy Optometrist US NPIs
Specialty board-certified rate — Vision Therapy Optometrist estimate
Board certification through an ABMS or AOA member board signals voluntary post-licensure examination plus Maintenance of Certification cycles. CMS does not publish a per-provider board-certification field; the figure shown is the specialty-level estimated rate from ABMS / AOA reference data.
The Merit-based Incentive Payment System (MIPS) scores providers 0–100 across four performance categories: Quality, Cost, Promoting Interoperability, and Improvement Activities, weighted under 42 CFR §414.1380. Reporting is voluntary for many small practices, so absence of a MIPS score is not a quality signal.
Board certification through an ABMS or AOA member board signals voluntary post-licensure examination plus continuous Maintenance of Certification cycles. Verify any individual provider's status through certificationmatters.org (ABMS) or osteopathic.org (AOA).
BENJAMIN LEISHMAN, OD is a Vision Therapy Optometrist provider practicing in SANDY, Utah, according to the CMS National Plan and Provider Enumeration System (NPPES). Credentials: OD. NPI: 1942438015. This profile includes practice location, specialty classification, and organizational affiliations from the CMS provider registry. Provider information is self-reported to CMS and updated monthly.
BENJAMIN LEISHMAN, OD appears in the CMS NPPES registry as a Vision Therapy Optometrist provider holding OD credentials at 9565 S 700 E STE 101, SANDY, UT, 84070, with a listed phone of (801) 572-3937. NPI 1942438015 was issued on 06/29/2009. Because NPPES data is self-reported by the provider and refreshed monthly, the address, phone, and specialty reflect what LEISHMAN most recently submitted to CMS rather than a vetted directory listing, which is why patients should always confirm the practice is still at this location before scheduling.
Medicare Part D records for calendar year 2023 show 39 prescription claims written by this provider, covering 13 Medicare beneficiaries and totaling roughly $225K in drug spend, split 51% brand-name and 49% generic by claim count. These figures capture only Medicare Part D — commercial insurance, Medicaid, and cash-pay prescriptions are not included, and any drug-beneficiary cell under 11 is suppressed by CMS for patient privacy.
Vision Therapy Optometrist is a narrow specialty nationwide, with 369 enrolled providers across 42 states and an average of 209 Part D claims per prescriber, so the context for interpreting these metrics differs meaningfully from a primary-care baseline. Important: PlainDoctor is a directory of publicly available government data, not medical advice, a malpractice database, or a quality rating. Inclusion here does not imply a recommendation, and absence of complaints or sanctions on this page does not mean none exist — always verify credentials through the NPPES NPI Registry, your state medical board, and the ABMS or AOA before making healthcare decisions.
Practice Address
Provider Details
| NPI | 1942438015 |
|---|---|
| Specialty | Vision Therapy Optometrist |
| Credentials | OD |
| Gender | Male |
| NPI Issued | 06/29/2009 |
Verify this provider's license
PlainDoctor pulls this profile from the CMS NPPES public registry. Confirm BENJAMIN LEISHMAN, OD's current license status, disciplinary history, and board certifications with the Utah Division of Professional Licensing in Utah before relying on this page for a clinical or care decision.
How we sourced this profile
Industry payments received (2024) — CMS Open Payments transparency data
The federal Physician Payments Sunshine Act (part of the Affordable Care Act) requires drug and medical-device manufacturers + group purchasing organizations to publicly report payments and other transfers of value to physicians and teaching hospitals. The data below covers 2024 for BENJAMIN LEISHMAN, OD. Source: openpaymentsdata.cms.gov.
Total received
$234
Largest payer
Alcon Vision LLC
Most common payment type
Food and Beverage
Industry payments are not necessarily indicators of bias — they include research funding, consulting fees for evidence-based work, royalties for inventions, food at conferences, and similar items. The disclosure exists for transparency. Read our methodology for how we interpret this data.
Brand vs generic prescribing mix · Brand-heavy
51% brand-name claims vs 49% generic, on 39 2023 Medicare Part D claims.
The federal Medicare Part D Generic Dispensing Rate national benchmark sits near 90% generic / 10% brand for primary-care prescribers, per CMS Office of the Actuary 2024 estimates. Higher brand share is common in specialty prescribing where generic equivalents are not available.
Medicare Part D Prescribing Data
CMS Medicare Part D prescriber-level data for calendar year 2023.
Prescribing Breakdown
- 30-Day Fills
- 86
- Total Day Supply
- 2,438
- Brand vs Generic
- 51% brand / 49% generic
- Brand Drug Cost
- $225K
- Generic Drug Cost
- $157
Patient Demographics
- Average Patient Age
- 74.7 years
- Avg HCC Risk Score
- 1.07
Top Prescribed Drugs (Medicare Part D)
Top drugs by claim count for calendar year 2023. Based on Medicare Part D data only.
| Drug | Claims |
|---|---|
| Latanoprost | 18 |
* Counts below 11 are suppressed by CMS for patient privacy. Generic names shown where available from CMS Part D data.
Vision Therapy Optometrist Overview
How BENJAMIN LEISHMAN, OD fits within the Vision Therapy Optometrist landscape nationally.
BENJAMIN LEISHMAN, OD's 39 claims are below the specialty average of 209.
Healthcare Guides
Learn more about finding, verifying, and understanding healthcare providers.
Explore Utah
Frequently Asked Questions
What is BENJAMIN LEISHMAN, OD's specialty? ▼
How much does BENJAMIN LEISHMAN, OD prescribe under Medicare Part D? ▼
Where is BENJAMIN LEISHMAN, OD located? ▼
What is BENJAMIN LEISHMAN, OD's NPI number? ▼
Does BENJAMIN LEISHMAN, OD prescribe more brand-name or generic drugs? ▼
How many Vision Therapy Optometrist providers are there in the US? ▼
What drugs does BENJAMIN LEISHMAN, OD prescribe most often? ▼
Does BENJAMIN LEISHMAN, OD accept Medicare? ▼
How can I verify BENJAMIN LEISHMAN, OD's credentials? ▼
Data Sources
- Provider Directory
- CMS National Plan and Provider Enumeration System (NPPES), download.cms.gov/nppes, updated monthly. Contains NPI, specialty, credentials, and practice location.
- Specialty Classification
- NUCC Health Care Provider Taxonomy (nucc.org), the industry standard for classifying provider specialties in Medicare and Medicaid billing.
- Prescribing Data
- CMS Medicare Part D Prescriber Public Use File (2023). Includes claims, drug costs, beneficiaries, and opioid prescribing rates.
- Limitations
- Provider data is self-reported to CMS. Prescribing data reflects Medicare Part D only and does not include commercial insurance, Medicaid, or cash prescriptions. Claims below 11 beneficiaries are suppressed by CMS for privacy.
See our complete data methodology for details on how we collect and process government data.
Data as of April 2026 (NPPES) / 2023 (Medicare Part D). Source: Centers for Medicare & Medicaid Services (CMS).
Disclaimer: Data from CMS NPPES and Medicare Part D. PlainDoctor does not rate or rank providers. Provider information is self-reported and may not be current. Always verify information directly with the provider. About · Methodology